Evidence map›Paper›PMID 30896859›Full record

ArticleInternational journal of oncology2019

[Corrigendum] Overexpression of SENP1 reduces the stemness capacity of osteosarcoma stem cells and increases their sensitivity to HSVtk/GCV.

Fengting Liu, Lili Li, Yanxia Li, Xiaofang Ma, Xiyun Bian, Xiaozhi Liu, Guowen Wang, Dianying Zhang

Abstract readPublished Erratum
In one paragraph

Article in International journal of oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Fengting LiuDepartment of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, P.R. China.
Lili LiDepartment of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, P.R. China.
Yanxia LiCentral Laboratory, The Fifth Central Hospital of Tianjin, Tianjin 300450, P.R. China.
Xiaofang MaDepartment of Trauma and Orthopedics, Peking University People's Hospital, Beijing 100044, P.R. China.
Xiyun BianCentral Laboratory, The Fifth Central Hospital of Tianjin, Tianjin 300450, P.R. China.
Xiaozhi LiuCentral Laboratory, The Fifth Central Hospital of Tianjin, Tianjin 300450, P.R. China.
Guowen WangDepartment of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, P.R. China.
Dianying ZhangDepartment of Trauma and Orthopedics, Peking University People's Hospital, Beijing 100044, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

After the publication of the article, the authors retrospectively noticed that the first author affiliation was incorrectly split across three affiliations for the various parts of the same address. The correct author list (and affiliations) should therefore have been published as follows: Fengting Liu1, Lili Li1, Yanxia Li2, Xiaofang Ma3, Xiyun Bian2, Xiaozhi Liu2, Guowen Wang1* and Dianying Zhang3* 1Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060; 2Central Laboratory, The Fifth Central Hospital of Tianjin, Tianjin 300450; 3Department of Trauma and Orthopedics, Peking University People's Hospital, Beijing 100044, P.R. China The authors regret that this error was allowed to remain in the published paper, and apologize for any inconvenience caused. [the original article was published in International Journal of Oncology 53: 2010‑2020, 2018; DOI: 10.3892/ijo.2018.4537].

Identifiers

PMID30896859
PMCPMC6521928

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.